BYMAVNI Trademark

Trademark Overview


On Tuesday, March 1, 2022, a trademark application was filed for BYMAVNI with the United States Patent and Trademark Office. The USPTO has given the BYMAVNI trademark a serial number of 97289759. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, January 24, 2025. This trademark is owned by Gilead Sciences Ireland UC. The BYMAVNI trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
bymavni

General Information


Serial Number97289759
Word MarkBYMAVNI
Filing DateTuesday, March 1, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, January 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarrigtohill, Co. Cork
IE

Trademark Events


Event DateEvent Description
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 4, 2022NEW APPLICATION ENTERED
Friday, March 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2022ASSIGNED TO EXAMINER
Monday, December 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 1 FILED
Thursday, August 3, 2023SOU EXTENSION 1 GRANTED
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2024SOU EXTENSION 3 GRANTED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024SOU EXTENSION 2 FILED
Wednesday, January 24, 2024SOU EXTENSION 2 GRANTED
Thursday, July 25, 2024SOU TEAS EXTENSION RECEIVED
Saturday, January 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 1, 2025SOU TEAS EXTENSION RECEIVED
Friday, January 24, 2025SOU EXTENSION 4 GRANTED
Thursday, July 25, 2024SOU EXTENSION 3 FILED
Friday, January 24, 2025SOU TEAS EXTENSION RECEIVED
Friday, January 24, 2025SOU EXTENSION 4 FILED